AIMS To define outcome measures for auditing the clinical care of children and adolescents with insulin dependent diabetes mellitus (IDDM) and to assess the benefit of appointing a dedicated paediatric trained diabetes specialist nurse (PDSN). Through grounded theories we previously explained why barriers to empowerment were seldom overcome in diabetes care. Costs of service provision were derived from district financial reports, costs of diabetes-related complications requiring hospitalisations were estimated from actual admission data and costed using published Diagnosis-Related Group costings in Australian dollars (year 2000). RESULTS Children under the care of ‘non-specialists’ had higher admission rates to hospital with all diabetes related problems and for hypoglycaemia and lower screening rates for microalbuminuria than those under ‘specialists’. In December 2009, the Federal Bureau of Prisons initiated a program to distribute glucose meters to insulin-dependent inmates to facilitate self-monitoring blood glucose. Establishing a goal for HbA1c (self-care management) and eating ≥2 snacks or desserts per day (self-care maintenance) were associated with a decrease in hospitalizations (IRR = 0.860, p = .001; IRR = 0.914, p = .043, respectively). Results The 62 chronic conditions varied in their relationships to diabetes care goal achievement for specific care goals.
This study indicates that the DES, the only available instrument to measure the concept of empowerment in diabetes care, is a sufficiently reliable and valid instrument in the Icelandic culture. It also shown that all drugs have side effects (e. Physicians may be achieving these results through more frequent visits and laboratory testing. Results Structural equation modeling demonstrated an excellent fit of two models depicting the mediating role of anticipated adherence difficulties and diabetes stress on the relationship between negative attributions of friend (first model) and peer (second model) reactions and metabolic control. Nonetheless, it’s not healed by treating symptoms with drugs that just perpetuate the state. Indeed, the original working name of the journal was to be Diabetes Health Care so that it could include both diabetes and general health care articles. Although our initial plan for the journal emphasized building on strength and implying stability over time, evolution is inevitable, particularly that forced upon us by changes in our academic environment.
Articles of Medicine journals are subjected to peer reviewing and these are included in the standard indexing databases like CAS, EBSCO, HINARI, Index Copernicus, SHERPA/RoMEO, Open J-Gate, AcademicKeys, JournalSeek, Ulrichsweb, WorldCat, etc. The BRFSS gathers data on preventive health practices and risk behaviors that are linked to chronic diseases, injuries, and preventable infectious diseases. The FIN-D2D had three major concurrent strategies: a high-risk strategy, early treatment strategy, and population strategy. Children with a daily step count lower than 10,000 steps/day had higher mean and maximum aIMT than those with higher step counts (0.56 ± 0.09 vs. Renal failure is mainly determined by a decrease in glomerular filtration rate, the rate at which blood is filtered in the glomeruli of the kidney. Family Practice 2004; 21: 39–45. The findings would be useful for performance assessment and management, benchmarking and incentivizing quality improvement.7 Identifying disparities of care is an important first step to address the problem.
The answers given by respondents to each of these eleven questions were collapsed into bifurcated categories. Continuing medical care requires different types of healthcare providers to aggressively manage other cardiometabolic risk factors, including blood pressure and lipid disturbances, in addition to ongoing patient self-management . The International Committee of Medical Journal Editors (ICMJE) has recognized the success of their initial policy and has made some recommendations for change (2). We agree with these changes and, in fact, are adopting them, effective immediately. At the time of the audit there were 154 children (81 girls and 73 boys) receiving diabetes care at the hospital. We are also implementing the ICMJE recommendation that only abstracts of results of 500 words or less can be posted on these Web sites before publication in our journal to avoid any appearance of duplicate publication. Another change to our policies came from the Association of American Medical Colleges (AAMC) guidelines on authorship of industry-sponsored clinical trials (http://www.aamc.org/research/clinicaltrialsreporting/start.htm).
When comparing the number of admissions to hospital, differing lengths of follow up were taken into account by using Poisson models, again using EGRET. While we welcome the increase in pharmaceutical funding for clinical trials and recognize that most are well conducted and the manuscripts well written, it is impossible for us to publish all but the most novel or those likely to have the greatest impact on clinical practice. We remind authors of their responsibility to verify the authenticity of the data and to avoid any potential accusation of ghost writing or gift authorship. We have also become conscious about possible duplicate publication; we are working with editors of other journals to detect any possible duplication of data in publication and are taking steps to censure authors who engage in such activities. This is particularly problematic in large multicenter and multi-author trials where post hoc analysis is frequently carried out. The last year or two has seen many developments in relation to the Food and Drug Administration (FDA) recommendations and labels for drugs used in the treatment of diabetes. We were therefore delighted that Dr.
Robert Misbin agreed to write a Commentary on the process for the December 2007 issue (3), making suggestions for drug development in the future. Again, in the interest of enlightening our readers to changes that occur in FDA recommendations, we propose to have a quarterly update on FDA-related issues that are relevant to diabetes. This created some interesting situations. Zachary Bloomgarden will add an FDA update to his well-established “Perspectives in the News,” perhaps on a quarterly basis. Several readers have questioned us about supplements and advertising supplements issued with the journal. It is our policy to review official supplements, which are called “supplements to Diabetes Care” and are indexed in PubMed. In contrast, any other material distributed with the journal should not be considered a journal supplement.
Accepted April 27, 2016. Kitabchi, MD, PhD; Anne Peters, MD; Robert P. Hoffman, MD; Elizabeth J. Mayer-Davis, MSPH, PhD, RD; Helaine E. The only re-coding efforts involved with these last three variables entailed the removal of missing data. In addition to the treatment- and outcomes-specific data reported separately , demographic and clinical characteristics from the time of T2DM diagnosis and at study enrolment were collected. Whitehouse, MD) and welcome the new ones.
In particular, I would like to thank the Associate Editors who have moved on to other responsibilities (Eli Ipp, MD, and Michael M. Engelgau, MD) and welcome Todd P. Gilmer, PhD, and Sam Dagogo-Jack, MD. We continue to have a strong team in place that will bring you the best clinical research and translational articles in diabetes.